[RCUS] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[RCUS] Arcus Biosciences, Inc.
Announcement Date
29-Sep-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -142.12%
YoY-
Quarter Report
RCUS's Result
RCUS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 32,000 33,581 9,461 64,530 1,750 4,291 163 140.98%
PBT -69,000 -64,919 -77,975 1,822 -22,352 -10,812 -23,122 19.97%
Tax 2,000 -4,478 -100 -258 -1,254 0 0 -
NP -71,000 -60,441 -77,975 1,822 -22,352 -10,812 -23,122 20.55%
Tax Rate - - - 14.16% - - - -
Total Cost 103,000 94,022 87,436 62,708 24,102 15,103 23,285 28.10%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -221.88 -179.99 -824.17 2.82 -1,277.26 -251.97 -14,185.28 -49.97%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.95 -0.84 -1.11 0.03 -0.51 -0.25 -0.94 0.17%
EPS Diluted -0.95 -0.84 -1.11 0.03 -0.51 -0.25 -0.94 0.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.